Logo image
Generation of leukotrienes by purified human lung mast cells
Journal article   Open access   Peer reviewed

Generation of leukotrienes by purified human lung mast cells

D W MacGlashan, R P Schleimer, S P Peters, E S Schulman, G K Adams, H H Newball and L M Lichtenstein
The Journal of clinical investigation, v 70(4), pp 747-751
01 Oct 1982
PMID: 7119113
url
https://doi.org/10.1172/jci110670View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open
url
https://doi.org/10.1172/JCI110670View
Published, Version of Record (VoR) Open

Abstract

Abridged Index Medicus
Although mediator release from mast cells and basophils plays a central role in the pathogenesis of human allergic disease, biochemical studies have been restricted to rat peritoneal mast cells and basophilic leukemia cells because they could be easily purified. We have used two new techniques of cell separation to purify human lung mast cells to 98% homogeneity. Lung cell suspensions were obtained by dispersion of chopped lung tissue with proteolytic enzymes. Mast cells were then purified from the suspensions by countercurrent centrifugal elutriation and affinity chromatography. The purified mast cells released both histamine and slow-reacting substance of anaphylaxis (SRS-A) (leukotriene C and D) during stimulation with goat anti-human IgE antibody. Moreover, these preparations were able to generate significant quantities of SRS-A (32 +/- 7 x 10(-17) LTD mole-equivalents/mast cell) at all stages of purification, indicating that a secondary cell is not necessary for the antigen-induced release of SRS.

Metrics

3 Record Views
224 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Medicine, Research & Experimental
Logo image